Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Long-Term Monitoring Study of the IMT-002 Patients
Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients
Status: Enrolling
Updated:  11/1/2017
Medical Center Ophthalmology
mi
from
San Antonio, TX
A Long-Term Monitoring Study of the IMT-002 Patients
Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients
Status: Enrolling
Updated: 11/1/2017
Medical Center Ophthalmology
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Long-Term Monitoring Study of the IMT-002 Patients
Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients
Status: Enrolling
Updated:  11/1/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
A Long-Term Monitoring Study of the IMT-002 Patients
Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients
Status: Enrolling
Updated: 11/1/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Phoenix, AZ
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Beverly Hills, CA
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Sacramento, CA
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Winter Haven, FL
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Wichita, KA
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Wichita, KA
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Bloomfield, NJ
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Charlotte, NC
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Abilene, TX
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Abilene, TX
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Santa Maria, CA
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Pensacola, FL
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Cleveland, OH
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
West Columbia, SC
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
West Columbia, SC
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Fort Myers, FL
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated:  11/2/2017
Opthea Investigative Site
mi
from
Willow Park, TX
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD
Status: Enrolling
Updated: 11/2/2017
Opthea Investigative Site
mi
from
Willow Park, TX
Click here to add this to my saved trials
Cataract Removal and Alzheimer's Disease
Therapeutic Effects of Cataract Removal in Alzheimer's Disease
Status: Enrolling
Updated:  11/7/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Cataract Removal and Alzheimer's Disease
Therapeutic Effects of Cataract Removal in Alzheimer's Disease
Status: Enrolling
Updated: 11/7/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cataract Removal and Alzheimer's Disease
Therapeutic Effects of Cataract Removal in Alzheimer's Disease
Status: Enrolling
Updated:  11/7/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Cataract Removal and Alzheimer's Disease
Therapeutic Effects of Cataract Removal in Alzheimer's Disease
Status: Enrolling
Updated: 11/7/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Sacramento, CA
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Winter Haven, FL
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Indianapolis, IN
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Grand Rapids, MI
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated:  11/7/2017
GSK Investigational Site
mi
from
Austin, TX
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration
An Open-label Pilot Study to Evaluate the Safety, Tolerability,Pharmacokinetics, Exploratory Efficacy and Pharmacodynamics of Oral Pazopanib Administered for 28 Days to Neovascular Age-relatedmacular Degeneration Patients
Status: Enrolling
Updated: 11/7/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated:  11/8/2017
UC Berkeley Clinica Research Center
mi
from
Berkeley, CA
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated: 11/8/2017
UC Berkeley Clinica Research Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated:  11/8/2017
CORL, Indiana University School of Optometry
mi
from
Indianapolis, IN
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated: 11/8/2017
CORL, Indiana University School of Optometry
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated:  11/8/2017
TERTC, University of Houston
mi
from
Houston, TX
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated: 11/8/2017
TERTC, University of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated:  11/8/2017
CCLR, University of Waterloo
mi
from
Waterloo,
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
Status: Enrolling
Updated: 11/8/2017
CCLR, University of Waterloo
mi
from
Waterloo,
Click here to add this to my saved trials
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated:  11/10/2017
GSK Investigational Site
mi
from
Minneapolis, MN
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated: 11/10/2017
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated:  11/10/2017
GSK Investigational Site
mi
from
Austin, TX
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated: 11/10/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated:  11/10/2017
GSK Investigational Site
mi
from
Tacoma, WA
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans
A Two-part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses of Pazopanib in Healthy Adult Subjects
Status: Enrolling
Updated: 11/10/2017
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers
A Randomized, Placebo-controlled, Double-masked, Parallel Group Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Repeat Doses of Pazopanib Eye Drops in Healthy Adult Subjects
Status: Enrolling
Updated:  11/10/2017
GSK Investigational Site
mi
from
Glendale, CA
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers
A Randomized, Placebo-controlled, Double-masked, Parallel Group Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Repeat Doses of Pazopanib Eye Drops in Healthy Adult Subjects
Status: Enrolling
Updated: 11/10/2017
GSK Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Chicago, IL
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Indianapolis, IN
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Kansas City, KA
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Boston, MA
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Detroit, MI
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Charleston, NC
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Charleston, NC
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Nashville, TN
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Dallas, TX
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated:  11/14/2017
Clinical Research Facility
mi
from
Madison, WI
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Status: Enrolling
Updated: 11/14/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
Genetic Analysis of Patients With Neovascular Age-Related Macular Degeneration Responsive to Ranibizumab But Resistant to Aflibercept
Status: Enrolling
Updated:  11/15/2017
Associated Retinal Consultants
mi
from
Royal Oak, MI
Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept
Genetic Analysis of Patients With Neovascular Age-Related Macular Degeneration Responsive to Ranibizumab But Resistant to Aflibercept
Status: Enrolling
Updated: 11/15/2017
Associated Retinal Consultants
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Safety and Efficacy of BRM421 for Dry Eye Syndrome
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Status: Enrolling
Updated:  11/20/2017
Central Maine Eye Care
mi
from
Lewiston, ME
Safety and Efficacy of BRM421 for Dry Eye Syndrome
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Status: Enrolling
Updated: 11/20/2017
Central Maine Eye Care
mi
from
Lewiston, ME
Click here to add this to my saved trials
Safety and Efficacy of BRM421 for Dry Eye Syndrome
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Status: Enrolling
Updated:  11/20/2017
Andover Eye Associates
mi
from
Andover, MA
Safety and Efficacy of BRM421 for Dry Eye Syndrome
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Status: Enrolling
Updated: 11/20/2017
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  11/21/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 11/21/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  11/21/2017
Clinical Research Facility
mi
from
Boston, MA
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 11/21/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  11/21/2017
Clinical Research Facility
mi
from
Portland, OR
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 11/21/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  11/21/2017
Clinical Research Facility
mi
from
Seattle, WA
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 11/21/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials